نتائج البحث - "Jan W. Eriksson"

1

Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes

المؤلفون: Prasad G. Kamble, Per Lundkvist, Russell Esterline, Maria J. Pereira, Anna Maria Langkilde, Jan W. Eriksson, Petros Katsogiannos, Eva Johnsson

المصدر: The Journal of Clinical Endocrinology & Metabolism. 104:193-201

مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Adamantane, Type 2 diabetes, 030204 cardiovascular system & hematology, Biochemistry, 0302 clinical medicine, Endocrinology, Insulin, Glucose tolerance test, Cross-Over Studies, medicine.diagnostic_test, digestive, oral, and skin physiology, Dipeptides, Middle Aged, Glucose clamp technique, Treatment Outcome, Female, hormones, hormone substitutes, and hormone antagonists, Adult, endocrine system, medicine.medical_specialty, Adolescent, Sodium, chemistry.chemical_element, 030209 endocrinology & metabolism, Context (language use), Glucagon, Young Adult, 03 medical and health sciences, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Sodium-Glucose Transporter 2 Inhibitors, Aged, Dipeptidyl-Peptidase IV Inhibitors, business.industry, Biochemistry (medical), Glucose Tolerance Test, medicine.disease, Crossover study, Diabetes Mellitus, Type 2, chemistry, Glucose Clamp Technique, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9981bf62860579717393278dbebf5d93Test
https://doi.org/10.1210/jc.2018-00969Test

2

Lower cardiorenal risk withsodium-glucosecotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases : A large multinational observational study

المؤلفون: Suguru Okami, Nils Kossack, Anna Norhammar, Issei Komuro, Marcus Thuresson, Dae Jung Kim, Johan Bodegard, Ruiqi Zhang, Kyoung Hwa Ha, Jil Billy Mamza, Toshitaka Yajima, Jan W. Eriksson, Amitava Banerjee, Takashi Kadowaki, Kåre I. Birkeland

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, heart failure, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Pharmacology, Endocrinology and Diabetes, digestive system, DPP-IV inhibitor, Diabetic nephropathy, 03 medical and health sciences, chemistry.chemical_compound, DPP‐IV inhibitor, 0302 clinical medicine, Endocrinology, Japan, Germany, Republic of Korea, Internal Medicine, Humans, Medicine, Dapagliflozin, Sodium-Glucose Transporter 2 Inhibitors, Dipeptidyl peptidase-4, Sweden, Dipeptidyl-Peptidase IV Inhibitors, Norway, business.industry, diabetic nephropathy, Sodium, SGLT2 inhibitor, Original Articles, dapagliflozin, Middle Aged, medicine.disease, Glucose, Diabetes Mellitus, Type 2, England, chemistry, Cardiovascular Diseases, Sodium/Glucose Cotransporter 2, Heart failure, Endokrinologi och diabetes, Female, Original Article, Observational study, observational study, SGLT2 Inhibitor, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb5d82cb5854d17dc2343c5a5c0528bTest
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-439121Test

3

A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes

المؤلفون: Jan Oscarsson, Peter J. Greasley, Jan W. Eriksson, Hiddo J.L. Heerspink, Viji Nair, Skander Mulder, Jonatan Hedberg, Wenjun Ju, Sunil B. Nagaraj, Ann Hammarstedt

المصدر: Diabetes, Obesity & Metabolism
Diabetes, Obesity and Metabolism

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, Renal function, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Pharmacology, Endocrinology and Diabetes, Kidney, Nephropathy, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Metabolomics, Glucosides, Diabetes mellitus, Internal Medicine, medicine, sodium-glucose co-transporter-2, Humans, Dapagliflozin, Benzhydryl Compounds, kidney function, Sodium-Glucose Transporter 2 Inhibitors, Symporters, business.industry, Sodium, Transporter, Original Articles, bioinformatics, dapagliflozin, medicine.disease, metabolomics, 3. Good health, Metabolic pathway, Glucose, chemistry, Diabetes Mellitus, Type 2, sodium‐glucose co‐transporter‐2, Endokrinologi och diabetes, Original Article, type 2 diabetes, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d417d44540cc7dd1c2beccd973a5516eTest
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-418709Test

4

Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes : A large multinational cohort study

المؤلفون: Elena Garal‐Pantaler, Takashi Kadowaki, Issei Komuro, Marcus Thuresson, Amitava Banerjee, Toshitaka Yajima, Jil Billy Mamza, Jan W. Eriksson, Suguru Okami, Gerard C.M. Linssen, Ruiqi Zhang, Kåre I. Birkeland, Hermann Haller, Anna Norhammar, Jetty Overbeek, Johan Bodegard

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, macrovascular disease, heart failure, 030209 endocrinology & metabolism, Type 2 diabetes, Disease, 030204 cardiovascular system & hematology, Endocrinology and Diabetes, Cohort Studies, Diabetic nephropathy, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Japan, Risk Factors, Germany, Internal medicine, Internal Medicine, medicine, Humans, Renal Insufficiency, Chronic, Netherlands, Macrovascular disease, Sweden, Norway, business.industry, diabetic nephropathy, SGLT2 inhibitor, Original Articles, medicine.disease, Diabetes Mellitus, Type 2, England, Heart failure, Endokrinologi och diabetes, Original Article, Observational study, observational study, type 2 diabetes, business, Kidney disease, Cohort study

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36442e9113c44f0f0cc73f21fe02428fTest
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-423708Test

5

Sleep apnea in men is associated with altered lipid metabolism, glucose tolerance, insulin sensitivity, and body fat percentage

المؤلفون: Karl A. Franklin, Jan W. Eriksson, Prasad G. Kamble, Ulf Hammar, Jenny Theorell-Haglöw, Urban Wiklund, Eva Lindberg

المصدر: Endocrine

مصطلحات موضوعية: Blood Glucose, Male, medicine.medical_specialty, Polysomnography, Endocrinology, Diabetes and Metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Endocrinology and Diabetes, Body fat percentage, Increased body fat percentage, 03 medical and health sciences, Sleep Apnea Syndromes, 0302 clinical medicine, Endocrinology, Insulin resistance, NEFA, stomatognathic system, Diabetes mellitus, Internal medicine, medicine, Humans, Insulin, Glucose metabolism, business.industry, Insulin secretion, Lipid Metabolism, medicine.disease, Obesity, Obstructive sleep apnea, nervous system diseases, respiratory tract diseases, Glucose, Lipid metabolism, Adipose Tissue, Diabetes Mellitus, Type 2, 030228 respiratory system, Endokrinologi och diabetes, Original Article, Insulin Resistance, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ebe1e5b5517defbc081618108509112Test
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-173463Test

6

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes ( CVD‐REAL Nordic ) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study

المؤلفون: Anna Norhammar, Bendix Carstensen, Johan Bodegard, David Nathanson, Marcus Thuresson, Thomas Nyström, Hanne L. Gulseth, Frederik Persson, Kåre I. Birkeland, Jan W. Eriksson, Marit E. Jørgensen, Peter Fenici

المصدر: Diabetes, Obesity and Metabolism. 20:344-351

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::45b254ad7bcf53ed6a5eff8483b51e18Test
https://doi.org/10.1111/dom.13077Test

7

Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: S ustained reductions in body weight, glycaemia and blood pressure over 1 year

المؤلفون: Per Lundkvist, Maria J. Pereira, C. David Sjöström, Jan W. Eriksson, Petros Katsogiannos, Eva Johnsson

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Male, obesity, Endocrinology, Diabetes and Metabolism, prediabetes, 030204 cardiovascular system & hematology, Body Mass Index, Impaired glucose tolerance, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Glucosides, Risk Factors, Prediabetes, Dapagliflozin, Adiposity, Middle Aged, Ghrelin, Cardiovascular Diseases, Endokrinologi och diabetes, Drug Therapy, Combination, Female, Original Article, medicine.drug, medicine.medical_specialty, exenatide, 030209 endocrinology & metabolism, Endocrinology and Diabetes, Placebo, Proof of Concept Study, Sodium-Glucose Transport Proteins, Drug Administration Schedule, Prediabetic State, 03 medical and health sciences, Double-Blind Method, Membrane Transport Modulators, Internal medicine, Diabetes mellitus, Weight Loss, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Benzhydryl Compounds, Sweden, Venoms, business.industry, Original Articles, dapagliflozin, medicine.disease, Impaired fasting glucose, chemistry, Anti-Obesity Agents, Peptides, business, Body mass index, Exenatide, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21c826239243e6eef8b385160c2f7fdfTest
https://doi.org/10.1111/dom.12954Test

8

Dapagliflozin vs non-SGLT-2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE-TIMI 58 trial: A nationwide observational study

المؤلفون: David Nathanson, Klas Rikner, Thomas Nyström, Marcus Thuresson, Anna Norhammar, Johan Bodegard, Jan W. Eriksson

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Population, 030209 endocrinology & metabolism, Type 2 diabetes, Endocrinology and Diabetes, 030204 cardiovascular system & hematology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Glucosides, Internal medicine, Health care, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Dapagliflozin, Benzhydryl Compounds, education, Sodium-Glucose Transporter 2 Inhibitors, Aged, Sweden, education.field_of_study, business.industry, Health Care Costs, Original Articles, Middle Aged, medicine.disease, Hospitalization, chemistry, Diabetes Mellitus, Type 2, Endokrinologi och diabetes, Propensity score matching, Inclusion and exclusion criteria, Observational study, Female, Original Article, business, TIMI

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e95ffc8694afbc5aabf5911187f98ba6Test
https://pubmed.ncbi.nlm.nih.gov/31379124Test

9

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial : A nationwide observational study

المؤلفون: David Nathanson, Thomas Nyström, Jan W. Eriksson, Anna Norhammar, Johan Bodegard, Marcus Thuresson

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Male, Endocrinology, Diabetes and Metabolism, 030204 cardiovascular system & hematology, Cohort Studies, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Glucosides, cardiovascular disease, Dapagliflozin, education.field_of_study, Clinical Trials as Topic, Hazard ratio, Middle Aged, Treatment Outcome, Cardiovascular Diseases, Research Design, Cohort, Endokrinologi och diabetes, Female, Original Article, type 2 diabetes, Cohort study, Adult, medicine.medical_specialty, Population, 030209 endocrinology & metabolism, Endocrinology and Diabetes, Lower risk, pharmaco-epidemiology, 03 medical and health sciences, Internal medicine, Internal Medicine, medicine, cohort study, Humans, Benzhydryl Compounds, education, Aged, Sweden, business.industry, Original Articles, dapagliflozin, pharmaco‐epidemiology, Confidence interval, chemistry, Diabetes Mellitus, Type 2, business, Mace, Diabetic Angiopathies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e12a906501d0f174e3f1fe700ab979Test
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-383151Test

10

Gastric Bypass Reduces Symptoms and Hormonal Responses in Hypoglycemia

المؤلفون: F. Anders Karlsson, Niclas Abrahamsson, Magnus Sundbom, Joey Lau Börjesson, Urban Wiklund, Jan W. Eriksson

المصدر: Diabetes. 65:2667-2675

مصطلحات موضوعية: Adult, Blood Glucose, Male, medicine.medical_specialty, Hydrocortisone, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Gastric Bypass, 030209 endocrinology & metabolism, Gastric Inhibitory Polypeptide, 030204 cardiovascular system & hematology, Hypoglycemia, Glucagon, Gastroenterology, 03 medical and health sciences, Catecholamines, 0302 clinical medicine, Gastric inhibitory polypeptide, Glucagon-Like Peptide 1, Weight loss, Internal medicine, Internal Medicine, medicine, Humans, Insulin, business.industry, Middle Aged, medicine.disease, Glucagon-like peptide-1, Obesity, Morbid, Endocrinology, Glucose Clamp Technique, Female, medicine.symptom, business, medicine.drug, Hormone

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8409b79d61d6810d4709b0887ad01f9bTest
https://doi.org/10.2337/db16-0341Test

تنقيح النتائج